Aflac's Japan Headwinds Meet a Valuation That Assumes They've Already Turned

Aflac Incorporated (AFL) reports first-quarter 2026 earnings tomorrow, April 29, after the market close, with analysts expecting EPS of $1.81 on revenue of approximately $4.30 billion. The central question is whether the supplemental insurance giant can sustain profitability momentum amid persistent currency headwinds from its critical Japan operations and ongoing interest rate volatility affecting investment income. With the stock trading at $116.29 and technical indicators showing strong bullish alignment across all timeframes, investors face a pivotal moment as AFL attempts to reverse a pattern of recent earnings disappointments.

Part 1: Earnings Preview

Aflac Incorporated is a leading supplemental insurance provider headquartered in Columbus, Georgia, offering policies designed to cover out-of-pocket health care and living expenses not typically paid by primary health insurance. The company operates primarily in the United States and Japan, with Japan representing its largest and most profitable market, generating significant exposure to yen-dollar currency fluctuations.

Aflac reports Q1 2026 earnings on April 29, 2026, after market close. Analysts expect EPS of $1.81 on revenue of approximately $4.30 billion. The company most recently reported Q4 2025 EPS of $1.57, which missed estimates by 8.19%. Compared to the same quarter last year (Q1 2025 EPS of $1.66), the consensus estimate implies year-over-year growth of 9.04%, suggesting analysts anticipate a rebound from recent underperformance.

Three key narrative themes define this earnings story:

1. Japan Currency Exposure and Investment Income Stability: Aflac's heavy reliance on Japan—where yen weakness versus the U.S. dollar has pressured reported earnings—remains the dominant concern. Investors will scrutinize management commentary on currency impacts and whether investment income from premium portfolios can offset foreign exchange headwinds amid continued interest rate volatility.

2. Premium Growth and Policy Retention Metrics: New sales momentum in both U.S. and Japan segments, along with persistency ratios (policy retention rates), will signal whether Aflac can sustain top-line growth. Premium income trends and the combined ratio measuring underwriting profitability are critical indicators of operational health.

3. Digital Transformation and Cost Control: CEO Daniel Amos is expected to address long-term strategies for customer retention and digital transformation at the upcoming Insurance Industry Summit in May. Investors want evidence that expense management initiatives are gaining traction and that technology investments are translating into competitive advantages.

Analyst sentiment heading into the release reflects cautious optimism. Goldman Sachs upgraded Aflac in Q4 2025 citing long-term profitability potential, while UBS downgraded in early 2026 due to market volatility concerns. The consensus maintains a neutral stance with a mean price target of $120.71, implying modest upside from current levels. JMP Securities and S&P Capital project Q1 revenue between $3.75 billion and $3.85 billion, with net income ranging from $1.3 billion to $1.4 billion. Analysts emphasize that effective cost control and expanding product lines remain key catalysts, though macro headwinds and sector-specific pressures continue to weigh on near-term expectations.

Part 2: Historical Earnings Performance

Aflac's recent earnings history reveals a volatile pattern of beats and misses, with performance swinging dramatically quarter to quarter. Over the past four quarters, the company has delivered two significant beats and two notable misses, creating uncertainty about execution consistency.

The most striking result came in Q3 2025 (September), when Aflac reported EPS of $2.49 against an estimate of $1.80, representing a massive 38.33% beat—the strongest surprise in the recent period. This exceptional performance was followed by a sharp reversal in Q4 2025 (December), where actual EPS of $1.57 missed the $1.71 estimate by 8.19%, marking the largest miss in the dataset. Q2 2025 (June) showed solid execution with EPS of $1.78 beating the $1.71 estimate by 4.09%, while Q1 2025 (March) delivered a modest miss with $1.66 versus $1.68 expected, down 1.19%.

The pattern suggests Aflac faces challenges maintaining consistent profitability, likely reflecting the currency volatility and interest rate fluctuations that analysts have highlighted. The dramatic Q3 outperformance appears to be an outlier rather than a sustainable trend, as the company has bookended that quarter with misses. Heading into Q1 2026, investors should approach with measured expectations—while the 9.04% year-over-year growth estimate signals optimism, Aflac's recent track record indicates execution risk remains elevated, particularly given ongoing macro headwinds in its Japan operations.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Aflac typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to actual numbers.

Aflac's post-earnings price behavior shows moderate Day 0 movement but significantly larger reactions on Day +1, consistent with after-hours reporting. The stock has averaged an absolute Day 0 move of 0.66% with a range of 2.03%, indicating relatively muted anticipatory trading. However, Day +1 tells a different story, with an average absolute move of 3.72% and a range of 4.57%, reflecting substantial volatility once results are digested.

The most dramatic recent reaction came after the April 2025 report, when the stock dropped 4.75% on Day +1 despite minimal Day 0 movement (0.07%), suggesting investors were caught off-guard by disappointing results or guidance. Similarly, the February 2025 and October 2024 reports triggered Day +1 declines of 3.92% and 4.81% respectively, demonstrating that misses or cautious outlooks can generate sharp selloffs. Conversely, the July 2024 report produced a strong 6.57% Day +1 gain, showing the stock can rally aggressively on positive surprises.

Investors should prepare for meaningful volatility following tomorrow's after-close release, with historical patterns suggesting a potential swing of 3-5% in either direction based on whether Aflac meets, beats, or misses expectations. The recent trend of Day +1 declines following disappointing quarters adds risk for bulls, though the stock has demonstrated it can reward strong execution with outsized gains.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 3.03% (approximately $3.53) through the May 1, 2026 expiration, which aligns closely with Aflac's historical Day +1 average absolute move of 3.72%. This suggests options traders are anticipating typical post-earnings volatility rather than an outsized reaction, though the historical range of 4.57% indicates potential for movement beyond the implied boundaries if results significantly surprise in either direction.

Part 3: What Analysts Are Saying

Analyst sentiment on Aflac reflects a cautious, neutral stance heading into earnings. The consensus rating stands at 3.19 (Hold territory) across 16 analysts, with the average price target of $120.71 implying approximately 3.8% upside from the current price of $116.29. The rating distribution shows 3 Strong Buys, 1 Moderate Buy, 10 Holds, and 2 Strong Sells, indicating most analysts prefer to wait for clearer evidence of sustained profitability before upgrading.

Sentiment has improved over the past month, with the consensus rating moving from 2.94 to 3.19 and Strong Buy recommendations increasing from 2 to 3 while Strong Sells decreased from 3 to 2. This shift suggests growing confidence among some analysts that Aflac's long-term fundamentals remain intact despite recent execution challenges. However, the dominant Hold contingent (10 of 16 analysts) reflects persistent concerns about currency headwinds, interest rate volatility, and the company's ability to deliver consistent earnings growth.

The wide range in price targets—from a low of $97.00 to a high of $236.00—underscores significant disagreement about Aflac's valuation and prospects. The high-end target implies potential upside exceeding 100%, likely reflecting bullish views on Japan market recovery and investment income stabilization, while the low-end target suggests downside risk of approximately 17% if macro headwinds intensify. The mean target's modest 3.8% upside indicates the Street is largely pricing in current challenges, with limited conviction for a near-term breakout absent a significant positive catalyst from tomorrow's earnings report.

Part 4: Technical Picture

Aflac enters earnings with exceptionally strong technical momentum, as the Barchart Technical Opinion has surged to a 100% Buy signal from just 24% Sell one month ago, marking a dramatic reversal in technical sentiment. The signal improved from 88% Buy last week, indicating accelerating bullish momentum in the immediate lead-up to the earnings release.

Timeframe Analysis:

• Short-term (100% Buy): Maximum bullish signal indicates powerful near-term momentum heading into earnings
• Medium-term (100% Buy): Strong buy signal across the intermediate timeframe suggests the uptrend has established firm support
• Long-term (100% Buy): Maximum bullish reading reflects strength across the entire trend structure, indicating broad-based technical health

Strong Strongest trend characteristics indicate Aflac is operating in an optimal technical environment with maximum momentum across all timeframes, providing a supportive backdrop for the earnings release.

The stock is trading at $116.29, positioned above all key moving averages: the 5-day ($115.09), 10-day ($114.73), 20-day ($112.94), 50-day ($111.41), 100-day ($111.04), and 200-day ($109.28). This complete alignment above all moving averages confirms the strength of the current uptrend and suggests technical support layers are well-established beneath current levels.

The technical setup heading into earnings is decidedly bullish, with AFL trading at multi-timeframe highs and maintaining clear separation above all major moving averages. The 200-day moving average at $109.28 represents the most significant support level, approximately 6% below current prices, providing a cushion should earnings disappoint. However, the stock's recent surge to $116.29 from levels near $112 just weeks ago suggests much of the positive sentiment may already be priced in, creating risk of a "sell the news" reaction even on solid results. The combination of maximum bullish technical signals and proximity to the mean analyst price target of $120.71 suggests limited upside runway unless Aflac delivers a significant beat with strong forward guidance. Traders should note that the stock is technically extended in the short term, making it vulnerable to profit-taking if results fail to exceed elevated expectations.